DCOY
Decoy Therapeutics
DCOY
DCOY
19 hedge funds and large institutions have $859K invested in Decoy Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
41% less capital invested
Capital invested by funds: $1.45M → $859K (-$591K)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$112K | |
| 2 | +$60.4K | |
| 3 | +$43.1K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$17.3K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$8.63K |
Top Sellers
| 1 | -$218K | |
| 2 | -$25.9K | |
| 3 | -$8.63K | |
| 4 |
Two Sigma Advisers
New York
|
-$8.63K |
| 5 |
SRC
Shufro Rose & Co
New York
|
-$7K |